07 Jan 2001

Concor® COR (Concor® COR 1,25 mg/-2,5 mg/-3,75 mg/-5 mg/-7,5 mg/-10 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Concor® COR 1,25 mg | -2,5 mg | -3,75 mg | -5 mg | -7,5 mg | -10 mg

Stabile chronische mittelgradige bis schwere Herzinsuffizienz bei eingeschränkter systolischer Ventrikelfunktion (EF zu ACE-Hemmern u. Diuretika, u. optional Herzglykosiden.

Concor® COR Description, Presentation and Dosage

Concor® COR Description

Concor® COR Drug Class Description


Concor® COR Drug Description

1 Filmtbl. enth.: Bisoprololhemifumarat 1,25 mg/2,5 mg/3,75 mg/5 mg/7,5 mg/10 mg.

Concor® COR Generic Name

Concor® COR 1,25 mg/-2,5 mg/-3,75 mg/-5 mg/-7,5 mg/-10 mg Filmtabletten

Concor® COR Presentation

Concor® COR Presentation

Concor® COR 1,25 mg/-2,5 mg/-3,75 mg/-5 mg/-7,5 mg/-10 mg

Concor® COR Manufacturer


Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Concor® COR Dosage

Concor® COR Adult Dosage

Hochdisperses Siliciumdioxid, Magnesiumstearat, Crospovidon, mikrokristalline Cellulose, Maisstärke, Calciumhydrogenphosphat, Dimeticon, Macrogol 400, E 171, Hypromellose, -1,25 mg zusätzl.: vorverkleisterte Stärke, -3,75 mg/-5 mg/-7,5 mg/-10 mg zusätzl.: E 172.

Concor® COR Precautions, Reactions and Contraindications

Concor® COR Special Precautions

Concor® COR Special Precautions

B 22 b-c, e-j. Akute od. dekomp. Herzinsuff. die i.v. Ther. m. inotropen Substanzen erfordert. Bradykardie (

Related Drugs - Cardiology

Back to top